Research
Hormonal
Semaglutide, administered via weekly subcutaneous injection, produces significant weight loss (mean 14.9% reduction) and improves insulin resistance, hypertension, and glycemia in adults with obesity (BMI ≥30 kg/m²).
Semaglutide is a weekly injection that helps you lose about 15% of your body weight and improves blood pressure and blood sugar. It works best when combined with a healthy diet and exercise. Common side effects like nausea are usually temporary. It is prescribed for people with a BMI of 30 or higher, or 27 or higher with health issues.
StrongSupportsHIGH confidence
Em Wilding et al. (2021) um Ensaio Clínico Randomizado (ECR), duplo cego, controlado com placebo, em 1961 adultos, com IMC acima de 30 kg/m², durante 68 semanas, foi demonstrado que os participantes em uso do medicamento apresentaram uma perda de peso média de 14,9% (-15,3 kg) do peso corporal inicial, em comparação com uma perda de 2,4% (-2,6 kg) observada no grupo placebo. Outros efeitos encontrados com o uso da semaglutida foram a melhora da resistência à insulina, redução da pressão arterial, e dos níveis de glicemia (Zhong et al., 2022).
Why this rating
Based on a large, double-blind, placebo-controlled randomized clinical trial (Wilding et al., 2021).
Source
TERAPIAS FARMACOLÓGICAS PARA TRATAR OBESIDADE: ANÁLISE DE EFEITO E EFICÁCIA
Túlio Martins Freitas et al. · Revista Foco · 2024
narrative_reviewCited 2×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →